62 related articles for article (PubMed ID: 2428259)
1. Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
Losonczy MF; Song IS; Mohs RC; Mathé AA; Davidson M; Davis BM; Davis KL
Am J Psychiatry; 1986 Sep; 143(9):1113-8. PubMed ID: 2428259
[TBL] [Abstract][Full Text] [Related]
2. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
Lewine RR; Risch SC; Risby E; Stipetic M; Jewart RD; Eccard M; Caudle J; Pollard W
Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
[TBL] [Abstract][Full Text] [Related]
3. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
Jennings WS; Schulz SC; Narasimhachari N; Hamer RM; Friedel RO
Psychiatry Res; 1985 Oct; 16(2):87-94. PubMed ID: 2415997
[TBL] [Abstract][Full Text] [Related]
4. Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
Boronow J; Pickar D; Ninan PT; Roy A; Hommer D; Linnoila M; Paul SM
Arch Gen Psychiatry; 1985 Mar; 42(3):266-71. PubMed ID: 2579616
[TBL] [Abstract][Full Text] [Related]
5. Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures.
Losonczy MF; Song IS; Mohs RC; Small NA; Davidson M; Johns CA; Davis KL
Am J Psychiatry; 1986 Aug; 143(8):976-81. PubMed ID: 3524278
[TBL] [Abstract][Full Text] [Related]
6. Clinical subtypes of schizophrenia: differences in brain and CSF volume.
Gur RE; Mozley PD; Shtasel DL; Cannon TD; Gallacher F; Turetsky B; Grossman R; Gur RC
Am J Psychiatry; 1994 Mar; 151(3):343-50. PubMed ID: 8109642
[TBL] [Abstract][Full Text] [Related]
7. Age and duration of illness as predictors of ventricular brain ratio (VBR) size in chronic schizophrenic patients. A stepwise regression analysis study.
Rossi A; Stratta P; Casacchia M; D'Albenzio L; Schiazza G; De Donatis M
Acta Psychiatr Scand; 1987 Sep; 76(3):256-60. PubMed ID: 3673652
[TBL] [Abstract][Full Text] [Related]
8. [Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
Nemtsov AV; Kalinin VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1232-41. PubMed ID: 6171962
[No Abstract] [Full Text] [Related]
9. [Homovanillic acid and 5--hydroxy-indoleacetic acid in the cerebrospinal fluid of man--concentration gradients between lumbar and ventricular CSF and variations in ventricular CSF-- (author's transl)].
Inagawa T; Kajihara S; Okada Y; Yoshimoto H; Mori S; Ishikawa S; Uozumi T
No To Shinkei; 1978 May; 30(5):565-74. PubMed ID: 666924
[No Abstract] [Full Text] [Related]
10. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the cerebrospinal fluid from the lateral ventricle of patients with brain tumors].
Majchrzak H; Kmieciak-Kołada K; Felińska W; Herman ZS; Wencel T
Neurol Neurochir Pol; 1986; 20(1):54-8. PubMed ID: 2423908
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relations in schizophrenia: brain morphology and neuropsychology.
Bilder RM
Prog Exp Pers Psychopathol Res; 1992; 15():183-251. PubMed ID: 1285281
[No Abstract] [Full Text] [Related]
12. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
Inagawa T
Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
Houston JP; Maas JW; Bowden CL; Contreras SA; McIntyre KL; Javors MA
Psychiatry Res; 1986 Nov; 19(3):207-14. PubMed ID: 3797547
[TBL] [Abstract][Full Text] [Related]
14. Suicide and aggression in schizophrenia. Neurobiologic correlates.
Pickar D; Roy A; Breier A; Doran A; Wolkowitz O; Colison J; Agren H
Ann N Y Acad Sci; 1986; 487():189-96. PubMed ID: 2436533
[TBL] [Abstract][Full Text] [Related]
15. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
[No Abstract] [Full Text] [Related]
16. Lateral ventricular enlargement in schizotypal personality disorder.
Siever LJ; Rotter M; Losonczy M; Guo SL; Mitropoulou V; Trestman R; Apter S; Zemishlany Z; Silverman J; Horvath TB
Psychiatry Res; 1995 Jul; 57(2):109-18. PubMed ID: 7480378
[TBL] [Abstract][Full Text] [Related]
17. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
Kirstein L; Bowers MB; Heninger G
Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
[TBL] [Abstract][Full Text] [Related]
18. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles.
Potkin SG; Weinberger DR; Linnoila M; Wyatt RJ
Am J Psychiatry; 1983 Jan; 140(1):21-5. PubMed ID: 6183980
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Chen YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
[No Abstract] [Full Text] [Related]
20. Eye-blinking and cerebral ventricular size in chronic schizophrenic patients.
Kleinman JE; Karson CN; Weinberger DR; Freed WJ; Berman KF; Wyatt RJ
Am J Psychiatry; 1984 Nov; 141(11):1430-2. PubMed ID: 6149700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
